Pure guessing.... somewhere between .05 - .10 but who really knows. It all depends on how many treatments that they have done and more importantly that they've done more than last reported. that number needs to continue upwards into this current quarter so the filing after this one would, IMO, be the one that truly garners some attention outside of us on this board.
The other thing that most of here expect is that their costs should not be significantly rising into subsequent quarters meaning that the additional revenue increases the potential for positive cash flow.
News 
Market Data 
Discover 
